A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Virchows Archiv

• Publication date

  2004-07-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00428-004-1053-xPMID 15258755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human pancreatic adenocarcinoma: In vitro and in vivo morphology of a new tumor line established from ascites

  2007cited by this paper
• A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes

  2004cited by this paper
• A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform

  2003cited by this paper
• The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity.

  2003cited by this paper
• TGF-β-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines

  2003cited by this paper
• Invasion and metastasis in pancreatic cancer

  2003cited by this paper
• Does the immune system see tumors as foreign or self?

  2003cited by this paper
• TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.

  2003cited by this paper
• New applications of gemcitabine and future directions in the management of pancreatic cancer

  2002cited by this paper
• Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1

  2002cited by this paper
• Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines.

  2002cited by this paper
• Tumor escape from killing: role of killer inhibitory receptors and acquisition of tumor resistance to cell death.

  2002cited by this paper
• Autocrine Production of Interleukin 1β Confers Constitutive Nuclear Factor κB Activity and Chemoresistance in Pancreatic Carcinoma Cell Lines

  2002cited by this paper
• The Role of Oxygen-Derived Free Radicals and Nitric Oxide in Cytokine-Induced Antiproliferation of Pancreatic Cancer Cells

  2002cited by this paper
• Pancreatic cancer biology and genetics

  2002cited by this paper
• Fas and Fas Ligand Expression in Pancreatic Adenocarcinoma

  2002cited by this paper
• Cytokines and chemoattractants in allergic inflammation.

  2002cited by this paper
• Cancer immunoediting: from immunosurveillance to tumor escape

  2002cited by this paper
• The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.

  2002cited by this paper
• Systemic and local immunosuppression in pancreatic cancer patients.

  2001cited by this paper
• Growth factors and their receptors in pancreatic cancer.

  2001cited by this paper
• Genetic profile of 22 pancreatic carcinoma cell lines

  2001cited by this paper
• Characterization of the mutations of the K-ras, p53, p16, and SMAD4 genes in 15 human pancreatic cancer cell lines.

  2001cited by this paper
• Ligation of the Fas antigen stimulates chemokine secretion in pancreatic cancer cell line PANC-1.

  2001cited by this paper
• Angiogenesis and cancer metastasis: antiangiogenic therapy of human pancreatic adenocarcinoma

  2001cited by this paper
• Pancreatic Cancer: Factors Regulating Tumor Development, Maintenance and Metastasis

  2001cited by this paper
• Current approaches and future strategies for pancreatic carcinoma.

  2000cited by this paper
• Current Approaches and Future Strategies for Pancreatic Carcinoma

  2000cited by this paper
• Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature.

  2000cited by this paper
• Vitamin D3 Affects Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells1

  2000cited by this paper
• Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.

  2000cited by this paper
• The Expression of Chemokine Genes Correlates with Nuclear Factor-&kgr;B Activation in Human Pancreatic Cancer Cell Lines

  2000cited by this paper
• A multispecialty approach to the diagnosis and management of pancreatic cancer

  2000cited by this paper
• Fas and Fas-ligand expression in human pancreatic cancer.

  2000cited by this paper
• Role for CD40-CD40 ligand interactions in the immune response to solid tumours.

  2000cited by this paper
• Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic.

  1999cited by this paper
• Immunological Escape Mechanisms in Pancreatic Carcinoma

  1999cited by this paper
• Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.

  1999cited by this paper
• Adenovirus-mediated TNF-alpha gene transfer induces significant tumor regression in mice.

  1999cited by this paper
• Adenovirus-mediated TNF-α Gene Transfer induces Significant Tumor Regression in Mice

  1999cited by this paper
• CD40 and epithelial cells: across the great divide.

  1998cited by this paper
• Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells

  1998cited by this paper
• HLA and cancer: from research to clinical impact.

  1998cited by this paper
• Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.

  1998cited by this paper
• Cancer statistics, 1997

  1997cited by this paper
• Pancreatic carcinoma in perspective: A continuing challenge

  1996cited by this paper
• Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors.

  1996cited by this paper
• Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line.

  1996cited by this paper
• The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines.

  1996cited by this paper
• DPC4 gene in various tumor types.

  1996cited by this paper
• Expression of MHC class I and class II antigens in pancreatic adenocarcinomas.

  1996cited by this paper
• New pancreas cancers cell lines that represent distinct stages of ductal differentiation.

  1995cited by this paper
• Comparative analysis of mutations in the p53 and K‐ras genes in pancreatic cancer

  1994cited by this paper
• A new monoclonal antibody (5D3-F7) which recognizes human monocyte-chemotactic protein-1 but not related chemokines. Development of a sandwich ELISA and in situ detection of producing cells.

  1994cited by this paper
• Structural analysis of a new highly metastatic cell line PaTu 8902 from a primary human pancreatic adenocarcinoma

  1993cited by this paper
• p53 and K-RAS alterations in pancreatic epithelial cell lesions.

  1993cited by this paper
• Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

  1991cited by this paper
• A cystic fibrosis pancreatic adenocarcinoma cell line.

  1990cited by this paper
• Pancreatic adenocarcinoma in a patient with cystic fibrosis.

  1988cited by this paper
• A new human pancreatic carcinoma cell line developed for adoptive immunotherapy studies with lymphokine-activated killer cells in nude mice

  1988cited by this paper
• Activation of the c-K-ras oncogene in a human pancreas carcinoma.

  1985cited by this paper
• Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinico‐histopathological correlation in a series of 75 cases

  1985cited by this paper
• Establishment and characterization of a carcinoembryonic antigen producing cell line derived from human pancreatic exocrine cancer

  1983cited by this paper
• Establishment and characterization of a carcinoembryonic antigen (CEA)‐producing cell line from a human carcinoma of the exocrine pancreas

  1983cited by this paper
• A continuing challenge

  1983cited by this paper
• Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.

  1982cited by this paper
• Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse: morphologic, biologic, and biochemical characteristics.

  1982cited by this paper
• Differential localization of human pancreas cancer-associated antigen and carcinoembryonic antigen in homologous pancreatic tumoral xenograft.

  1981cited by this paper
• Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

  1977cited by this paper
• Human pancreatic carcinoma (mia paca‐2) in continuous culture: Sensitivity to asparaginase

  1977cited by this paper
• Epithelial cell cultures from normal and cancerous human tissues.

  1976cited by this paper
• Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas

  1975cited by this paper

• Coffee Wastes: A Sustainable Source of Natural Compounds Suppressing Colorectal Cancer Cell Viability

  2025cites this paper
• Cancer Cell-Derived Exosomal miR-519a/522-5p Promotes Pancreatic Cancer Progression by Enhancing Warburg Effect

  2025cites this paper
• Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity

  2024cites this paper
• Tissue-resident NK cells support survival in pancreatic cancer through promotion of cDC1-CD8T activity

  2024cites this paper
• A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma

  2022cites this paper
• Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway

  2022influential citation
• Jawbone Cavitation Expressed RANTES/CCL5: Case Studies Linking Silent Inflammation in the Jawbone with Epistemology of Breast Cancer

  2021cites this paper
• Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression

  2020cites this paper
• Progress in Animal Models of Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• A Biomimetic Tumor Model of Heterogeneous Invasion in Pancreatic Ductal Adenocarcinoma.

  2020cites this paper
• Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes

  2020cites this paper
• Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor.

  2019cites this paper
• Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.

  2019cites this paper
• Combination treatment of resveratrol and capsaicin radiosensitizes pancreatic tumor cells by unbalancing DNA repair response to radiotherapy towards cell death.

  2019cites this paper
• Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome.

  2018cites this paper
• Novel Mitochondria-Targeted Furocoumarin Derivatives as Possible Anti-Cancer Agents

  2018influential citation
• Sensibilisation de l’adénocarcinome pancréatique canalaire à la chimiothérapie et à la radiothérapie par des molécules bioactives issues de l’alimentation

  2018cites this paper
• Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer.

  2017cites this paper
• Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model.

  2017cites this paper
• Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractivity

  2016cites this paper
• Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness

  2016cites this paper
• Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer.

  2016cites this paper
• Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness.

  2016cites this paper
• Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma

  2016cites this paper
• Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin-Fusion Protein Nanocarriers Bearing Proline, Serine, and Alanine Elements.

  2016cites this paper
• Gemcitabine-releasing mesenchymal stromal cells inhibit in vitro proliferation of human pancreatic carcinoma cells.

  2015cites this paper
• Chondroitin Sulfate Proteoglycan CSPG4 as a Novel Hypoxia-Sensitive Marker in Pancreatic Tumors

  2014cites this paper
• The immune network in pancreatic cancer development and progression

  2014cites this paper
• Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1α in pancreatic cancer cells.

  2014cites this paper
• Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell lines.

  2014cites this paper
• Expression of Foxp3, CD25 and IL-2 in the B16F10 cancer cell line and melanoma is correlated with tumor growth in mice

  2013cites this paper
• EINFLUSS VON CATECHINGALLAT AUF PROLIFERATION UND TRAIL- VERMITTELTE APOPTOSE VON PANKREASTUMORZELLEN

  2012cites this paper
• Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines

  2012cites this paper
• Metabolic Profiling Comparison of Human Pancreatic Ductal Epithelial Cells and Three Pancreatic Cancer Cell Lines using NMR Based Metabonomics

  2012cites this paper
• FBS: Fetal Bovine Serum; GalNAc: N-Acetylgalactosamine; GC-MS: Gas Chromatography Mass Spectrometry; GlcNAc: N-Acetylglucosamine; H6C7: Immortalized Human Pancreatic Ductal Epithelial Cell Line; HPDE6-E6E76c7: HDPE Human Ductal Pancreatic Epithelial; LC- MS, Liquid Chromatography Mass Spectrometry;

  2012cites this paper
• Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment

  2012cites this paper
• MHC class II expression in pancreatic tumors: a link to intratumoral inflammation

  2011cites this paper
• Leukocytes as paracrine regulators of metastasis and determinants of organ‐specific colonization

  2011cites this paper
• Nanomaterials and Block Copolymers for Overcoming Multidrug Resistance in Cancer

  2011influential citation
• Low expression of aldehyde deyhdrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer

  2011cites this paper
• Phenotype and Genotype of Pancreatic Cancer Cell Lines

  2010cites this paper
• Secretome analysis of multiple pancreatic cancer cell lines reveals perturbations of key functional networks.

  2010cites this paper
• Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer

  2010cites this paper
• Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.

  2010cites this paper
• Membrane Drug Transporters and Chemoresistance in Human Pancreatic Carcinoma

  2010cites this paper
• Foxp3-Mediated Immunity of Human Pancreatic Cancer Cell Line PANC-1

  2009cites this paper
• Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer1

  2009cites this paper
• Establishment and Characterization of 4 New Human Pancreatic Cancer Cell Lines: Evidences of Different Tumor Phenotypes

  2009cites this paper
• Constitutive noncanonical NFκB signaling in pancreatic cancer cells

  2009cites this paper
• Adenoviral‐mediated gene transfer of Gadd45a results in suppression by inducing apoptosis and cell cycle arrest in pancreatic cancer cell

  2009cites this paper
• a Murine Model of Pancreatic Cancer inRegulatory T Cells Inhibits Tumor Growth Disruption of CCR 5-Dependent Homing of

  2009cites this paper
• Serological immunoreactivity against colon cancer proteome varies upon disease progression.

  2008cites this paper
• CXCL14 expression and potential function in pancreatic cancer.

  2008cites this paper
• Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.

  2008cites this paper
• ATP-Binding Cassette C Transporters in Human Pancreatic Carcinoma Cell Lines

  2008cites this paper
• Tumor-derived CCL5 does not contribute to breast cancer progression

  2008cites this paper
• Determination of the Ligand-Binding Specificities of the &agr;2&bgr;1 and &agr;1&bgr;1 Integrins in a Novel 3-Dimensional In Vitro Model of Pancreatic Cancer

  2007cites this paper
• The Integrin-Extracellular Matrix Axis in Pancreatic Cancer

  2007cites this paper
• The α2β1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines

  2006cites this paper
• Chemokines and their receptors in the metastatic behaviour of human pancreatic ductal adenocarcinoma

  2006cites this paper
• Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer

  2006cites this paper
• Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation

  2006cites this paper
• Recent Advances on the Molecular Mechanisms Involved in Pancreatic Cancer Progression and Therapies

  2005cites this paper
• Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase migration, and decrease PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells

  2005cites this paper
• Antiangiogenic Treatment with Three Thrombospondin-1 Type 1 Repeats versus Gemcitabine in an Orthotopic Human Pancreatic Cancer Model

  2005cites this paper
• Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis

  2005cites this paper
• Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4

  2004cites this paper